In Vitro Inhibition of Staphylococcus aureus subsp. aureus (ATCC® 6538™) by Artemether-Lumefantrine Tablets: A Comparative Study of Three Dosage Strengths

All published articles of this journal are available on ScienceDirect.

CORRIGENDUM

In Vitro Inhibition of Staphylococcus aureus subsp. aureus (ATCC® 6538™) by Artemether-Lumefantrine Tablets: A Comparative Study of Three Dosage Strengths

Opoku Solomon1 , * Open Modal Nyanor Isaac2
Authors Info & Affiliations
The Open Microbiology Journal • 13 Mar 2019 • CORRIGENDUM • DOI: 10.2174/1874285801913010067

In Vitro Inhibition of Staphylococcus aureus subsp. aureus (ATCC® 6538™) by Artemether-Lumefantrine Tablets: A Comparative Study of Three Dosage Strengths

The Open Microbiology Journal, 2018, 12: 397-403.

1- The correct word in running title in header is mentioned below:

aureus subsp.

The original word in running title in header was:

Aureus subsp.

2- The following unnecessary text was removed from the page number 400 & 401.

  • This table is modified from Clinical and Laboratory Standards Institute. (2016). Performance standards for antimicrobial susceptibility testing; 26th ed. CLSI M100S. Clinical and Laboratory Standards Institute, Wayne, PA.
  • These are footnote texts for Tables 1 and 2. Should be cut and pasted at the appropriate places.